Skip to main content

Advertisement

Articles

Page 1 of 43

  1. Content type: Correction

    In the original publication of this article [1], there is an error in Fig. 4A.

    Authors: Jia Wei, Ling Ma, Yi-Hui Lai, Ruijie Zhang, Huameng Li, Chenglong Li and Jiayuh Lin

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:374

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:63

  2. Content type: Research

    An increasing number of anticancer agents has been proposed in recent years with the attempt to overcome treatment-resistant cancer cells and particularly cancer stem cells (CSC), the major culprits for tumour...

    Authors: Isabella Orienti, Valentina Salvati, Giovanni Sette, Massimo Zucchetti, Lucilla Bongiorno-Borbone, Angelo Peschiaroli, Lello Zolla, Federica Francescangeli, Mariella Ferrari, Cristina Matteo, Ezia Bello, Antonio Di Virgilio, Mario Falchi, Maria Laura De Angelis, Marta Baiocchi, Gerry Melino…

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:373

    Published on:

  3. Content type: Research

    The interaction between tumor cells and their immunosuppressive microenvironment promotes tumor progression and drug resistance. Thus, simultaneously targeting tumor cells and stromal cells is expected to have...

    Authors: Xia Peng, Pengcong Hou, Yi Chen, Yang Dai, Yinchun Ji, Yanyan Shen, Yi Su, Bo Liu, Yueliang Wang, Deqiao Sun, Yuchen Jiang, Chuantao Zha, Zuoquan Xie, Jian Ding, Meiyu Geng and Jing Ai

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:372

    Published on:

  4. Content type: Research

    Arachidonic acid (AA) metabolic enzymes including cyclooxygenase-2 (COX-2), microsomal prostaglandin E synthase-1 (mPGES-1) and cytochrome P450 (CYP) 4A11 play important roles in glioma angiogenesis. Thus, the...

    Authors: Chenlong Wang, Yaxin Chen, Yang Wang, Xiaoxiao Liu, Yanzhuo Liu, Ying Li, Honglei Chen, Chengpeng Fan, Dongfang Wu and Jing Yang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:371

    Published on:

  5. Content type: Research

    Topoisomerase inhibitors (TI) can inhibit cell proliferation by preventing DNA replication, stimulating DNA damage and inducing cell cycle arrest. Although these agents have been commonly used in the chemother...

    Authors: Jiafei Liu, Like Qu, Lin Meng and Chengchao Shou

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:370

    Published on:

  6. Content type: Research

    Esophageal squamous cell carcinoma (ESCC) is one of the most common cancers worldwide, which lacks effective biomarkers for prognosis. Therefore, it is urgent to explore new potential molecular markers to disc...

    Authors: Yan Liu, Yingru Zhi, Haizhu Song, Mingzhu Zong, Jun Yi, Guoxin Mao, Longbang Chen and Guichun Huang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:369

    Published on:

  7. Content type: Review

    Survivin (also named BIRC5) is a well-known cancer therapeutic target. Since its discovery more than two decades ago, the use of survivin as a target for cancer therapeutics has remained a central goal of surv...

    Authors: Fengzhi Li, Ieman Aljahdali and Xiang Ling

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:368

    Published on:

  8. Content type: Correction

    In the publication of this article [1], there is an error in Fig. 5C (panel 4, group of InmiR-26a + silinc01296 in SW620). The revised Fig. 5 which includes 5C has now been included in this correction.

    Authors: Bing Liu, Shimeng Pan, Yang Xiao, Qianqian Liu, Jingchao Xu and Li Jia

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:367

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2018 37:316

  9. Content type: Research

    The epithelial-to-mesenchymal transition (EMT) has been linked to the regulation of glioma progression. However, the underlying signaling mechanisms that regulate EMT are poorly understood.

    Authors: Erbao Bian, Xueran Chen, Yadi Xu, Xinghu Ji, Meng Cheng, Hongliang Wang, Zhiyou Fang and Bing Zhao

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:366

    Published on:

  10. Content type: Research

    The lncRNA LINC00460 plays crucial roles in several epithelial cancers, although its mechanisms of action differ greatly in different cellular contexts. In this study, we aimed to determine the potential clini...

    Authors: Yingying Jiang, Wei Cao, Kun Wu, Xing Qin, Xiaoning Wang, Yan Li, Binbin Yu, Zhen Zhang, Xu Wang, Ming Yan, Qin Xu, Jianjun Zhang and Wantao Chen

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:365

    Published on:

  11. Content type: Research

    Microsatellite unstable colorectal cancers (MSI+ CRCs) expressing PD-L1, respond to anti-PD-1 or anti-PD-L1 checkpoint blockade, whereas microsatellite-stable tumors do not respond the same. Our aim was to exa...

    Authors: Apostolos Zaravinos, Constantinos Roufas, Majdi Nagara, Beatriz de Lucas Moreno, Maria Oblovatskaya, Christodoulos Efstathiades, Christos Dimopoulos and Georgios D. Ayiomamitis

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:364

    Published on:

  12. Content type: Research

    In order to develop a new immunotherapeutic agent targeting metastatic breast cancers, we chose to utilize autocatalytic feature of the membrane serine protease Prss14/ST14, a specific prognosis marker for ER ...

    Authors: Ki Yeon Kim, Minsang Yoon, Youngkyung Cho, Kwang-Hoon Lee, Sora Park, Se-ra Lee, So-Young Choi, Deokjae Lee, Chansik Yang, Eun Hye Cho, Sangjun Davie Jeon, Seok-Hyung Kim, Chungho Kim and Moon Gyo Kim

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:363

    Published on:

  13. Content type: Research

    Tumor targeting small molecular inhibitors are the most popular treatments for many malignant diseases, including cancer. However, the lower clinical response and drug resistance still limit their clinical eff...

    Authors: Xiaoge Gao, Pin Jiang, Qian Zhang, Qian Liu, Shuangshuang Jiang, Ling Liu, Maomao Guo, Qian Cheng, Junnian Zheng and Hong Yao

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:362

    Published on:

  14. Content type: Research

    Triple Negative Breast cancer (TNBC) is incurable cancer with higher rates of relapse and shorter overall survival compared with other subtypes of breast cancer. Cellular retinoic acid binding protein 2 (CRABP...

    Authors: Xuefei Feng, Miao Zhang, Bo Wang, Can Zhou, Yudong Mu, Juan Li, Xiaoxu Liu, Yaochun Wang, Zhangjun Song and Peijun Liu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:361

    Published on:

  15. Content type: Research

    A major limitation in the treatment for malignant mesothelioma is related to serious side effects caused by chemotherapeutics and to the development of cancer-resistance. Advances in cancer therapies have been...

    Authors: Francesco Di Meo, Stefania Filosa, Michele Madonna, Gerarda Giello, Alba Di Pardo, Vittorio Maglione, Alfonso Baldi and Stefania Crispi

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:360

    Published on:

  16. Content type: Research

    Epidemiological observations have demonstrated that ambient fine particulate matter with dp < 2.5 μm (PM2.5) as the major factor responsible for the increasing incidence of lung cancer in never-smokers. However, ...

    Authors: Ming-Yue Li, Li-Zhong Liu, Wende Li, Calvin S. H. Ng, Yi Liu, Angel W. Y. Kong, Zhili Zhao, Shanshan Wang, Haolong Qi, Hao Jia, Shucai Yang, Jing Du, Xiang Long, Rocky L. K. Ho, Ernest C. W. Chak, Innes Y. P. Wan…

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:359

    Published on:

  17. Content type: Research

    MicroRNAs (miRNAs) play crucial roles in tumor initiation and development. Previously, we indicated that miR-504 is downregulated and suppresses tumor proliferation in glioblastoma (GBM). However, the regulati...

    Authors: Qiang Liu, Yanlei Guan, Zhenhang Li, Yao Wang, Yu Liu, Run Cui and Yunjie Wang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:358

    Published on:

  18. Content type: Correction

    In the original publication of this article [1], there is a mistake in Fig. 4E.

    Authors: Qianqian Liu, Hongye Ma, Xiuhua Sun, Bing Liu, Yang Xiao, Shimeng Pan, Huimin Zhou, Weijie Dong and Li Jia

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:357

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:199

  19. Content type: Research

    Long noncoding RNAs (lncRNAs) have been reported to be associated with the proliferation of several cancer cells. The aim of this study was to investigate the role of FLVCR1-AS1 in ovarian serous cancer (OSC).

    Authors: Huan Yan, Hong Li, Maria A. Silva, Yichun Guan, Li Yang, Linlin Zhu, Zhan Zhang, Genxia Li and Chenchen Ren

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:356

    Published on:

  20. Content type: Research

    Human epidermal growth factor receptor 2 (HER2) is overexpressed in multiple cancers, which is associated with poor prognosis. Herceptin and other agents targeting HER2 have potent antitumor efficacy in patien...

    Authors: Shengnan Yu, Jing Zhang, Yongxiang Yan, Xudong Yao, Lijuan Fang, Hui Xiong, Yang Liu, Qian Chu, Pengfei Zhou and Kongming Wu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:355

    Published on:

  21. Content type: Research

    Estrogen receptor β (ERβ) has been reported to play an anti-cancer role in breast cancer, but the regulatory mechanism by which ERβ exerts this effect is not clear. Claudin-6 (CLDN6), a tight junction protein,...

    Authors: Peiye Song, Yanru Li, Yuan Dong, Yingying Liang, Huinan Qu, Da Qi, Yan Lu, Xiangshu Jin, Yantong Guo, Yiyang Jia, Xinqi Wang, Wenhong Xu and Chengshi Quan

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:354

    Published on:

  22. Content type: Research

    Tubeimoside-I (TBM), a plant-derived bioactive compound, shows antitumor activity in different tumors and can enhance the efficacy of chemotherapeutic agents. However, the detail mechanism underlying remains t...

    Authors: Jianghong Yan, Xiaoyun Dou, Jing Zhou, Yuanfeng Xiong, Ling Mo, Longhao Li and Yunlong Lei

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:353

    Published on:

  23. Content type: Correction

    In the original publication of this article [1], the author’ affiliations need to be revised, because the first and second affiliations should combine as the same affiliation.

    Authors: Haoming Mai, Bin Zhou, Li Liu, Fu Yang, Carly Conran, Yuan Ji, Jinlin Hou and Deke Jiang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:352

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:198

  24. Content type: Research

    Soluble fibrinogen-like protein 2 (sFGL2), a secretory protein expressed by regulatory T cells (Tregs) with immunosuppressive activity, is highly expressed in both the peripheral blood and tumor tissue of pati...

    Authors: Muyang Yang, Zhongwei Zhang, Jiajia Chen, Mengying Xu, Jiaquan Huang, Ming Wang, Weina Li, Xiaoyang Wan, Man-Fung Yuen, Xiaoping Luo, Dong Xi and Qin Ning

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:351

    Published on:

  25. Content type: Research

    Ubiquitin E3 ligase CUL4A plays important oncogenic roles in the development of cancers. DTL, one of the CUL4-DDB1 associated factors (DCAFs), may involve in the process of cancer development. Programmed cell ...

    Authors: Haoran Cui, Qin Wang, Zhenchuan Lei, Maoxiao Feng, Zhongxi Zhao, Yunshan Wang and Guangwei Wei

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:350

    Published on:

  26. Content type: Research

    Over the past decade, newly designed cancer therapies have not significantly improved the survival of patients diagnosed with Malignant Pleural Mesothelioma (MPM). Among a limited number of genes that are freq...

    Authors: Claudio Pulito, Etleva Korita, Andrea Sacconi, Mariacristina Valerio, Luca Casadei, Federica Lo Sardo, Federica Mori, Maria Ferraiuolo, Giuseppe Grasso, Anna Maidecchi, Jacopo Lucci, Marius Sudol, Paola Muti, Giovanni Blandino and Sabrina Strano

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:349

    Published on:

  27. Content type: Research

    Ten-eleven translocation 1 (TET1) is a dioxygenase that converts 5-methylcytosine (5-mC) to 5-hydroxymethylcytosine (5-hmC) to induce DNA demethylation. TET1 has been reported to be absent in cancers, and to i...

    Authors: Jian Wu, Hongzhe Li, Minmin Shi, Youwei Zhu, Yang Ma, Yiming Zhong, Cheng Xiong, Hao Chen and Chenghong Peng

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:348

    Published on:

  28. Content type: Research

    Pancreatic cancer is a highly lethal malignancy with poor prognosis. Anillin (ANLN), an actin binding protein, is upregulated and plays an important role in many malignant tumors. However, the precise role of ...

    Authors: Anbin Wang, Haisu Dai, Yi Gong, Chengcheng Zhang, Junjie Shu, Yuandeng Luo, Yan Jiang, Wei Liu and Ping Bie

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:347

    Published on:

  29. Content type: Research

    RUNX2 is a Runt-related transcription factor required during embryogenesis for skeletal development and morphogenesis of other organs including thyroid and breast gland. Consistent evidence indicates that RUNX...

    Authors: Gloria Manzotti, Federica Torricelli, Benedetta Donati, Valentina Sancisi, Mila Gugnoni and Alessia Ciarrocchi

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:346

    Published on:

  30. Content type: Research

    Epithelial ovarian cancer (EOC) is the malignant tumor of the female reproductive system with the highest fatality rate. Tolerance of chemotherapeutic drugs like cisplatin (DDP) occurring in very early stage i...

    Authors: Xiaoran Long, Keqi Song, Hao Hu, Qi Tian, Wenjing Wang, Qian Dong, Xia Yin and Wen Di

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:345

    Published on:

  31. Content type: Research

    Accumulated evidences have demonstrated that long non-coding RNAs (lncRNAs) are dysregulated and correlate with the pathophysiological basis of malignant tumors. The objective of this research is to uncover th...

    Authors: Chen Qi, Chen Xiaofeng, Li Dongen, Yang Liang, Xu Liping, Hu Yue and Jiang Jianshuai

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:344

    Published on:

  32. Content type: Research

    Kidney Renal Clear Cell Carcinoma (KIRC) accounts for 75% of all renal cancers. Previous study had conflict evidences regarding NR1B2 role in cancer, and its expression and biological role in KIRC remained unc...

    Authors: Lei Yin, Wenjia Li, Guangchun Wang, Heng Shi, Keyi Wang, Huan Yang and Bo Peng

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:343

    Published on:

  33. Content type: Research

    Androgen receptor (AR)-targeted treatments improve the survival of castration-resistant prostate cancer (CRPC) patients; however, secondary resistance to these agents ultimately occurs in virtually all patient...

    Authors: Sahyun Pak, Sejun Park, Yunlim Kim, Jung-Hyuck Park, Chan-Hee Park, Kyoung-June Lee, Choung-soo Kim and Hanjong Ahn

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:342

    Published on:

  34. Content type: Research

    Prostate tumor over expressed gene 1 (PTOV1) has been reported as an oncogene in several human cancers. However, the clinical significance and biological role of PTOV1 remain elusive in non-small cell lung can...

    Authors: Zhiqiang Wu, Zhuang Liu, Xiangli Jiang, Zeyun Mi, Maobin Meng, Hui Wang, Jinlin Zhao, Boyu Zheng and Zhiyong Yuan

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:341

    Published on:

  35. Content type: Research

    Pancreatic ductal adenocarcinoma is one of the most aggressive cancers, with a 5-year survival rate of less than 8%. The complicated tumor microenvironment, particularly TGF-β, provides possible convenience fo...

    Authors: Ruizhi He, Min Wang, Chunle Zhao, Ming Shen, Yahong Yu, Li He, Yan Zhao, Hua Chen, Xiuhui Shi, Min Zhou, Shutao Pan, Yuhui Liu, Xingjun Guo, Xu Li and Renyi Qin

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:340

    Published on:

  36. Content type: Research

    Glioma initiating cells (GICs), also known as glioma stem cells (GSCs), play an important role in the progression and recurrence of glioblastoma multiforme (GBM) due to their potential for self-renewal, multip...

    Authors: Li Yi, Xingchen Zhou, Tao Li, Peidong Liu, Long Hai, Luqing Tong, Haiwen Ma, Zhennan Tao, Yang Xie, Chen Zhang, Shengping Yu and Xuejun Yang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:339

    Published on:

  37. Content type: Research

    The GKN2 is a secretory protein, whose levels decrease in gastric cancer. The present study aimed to investigate the expression, function and mechanism of action of GKN2 in gastric cancer.

    Authors: Ziqiang Zhang, Hongyuan Xue, Yuanqiang Dong, Jun Zhang, Yida Pan, Liubin Shi, Panpan Xiong, Jie Zhu, Wenshuai Li, Wanwei Zheng, Jie Liu and Jianjun Du

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:338

    Published on:

  38. Content type: Research

    Metabolic rewiring is a common feature of many cancer types, including prostate cancer (PCa). Alterations in master genes lead to mitochondrial metabolic rewiring and provide an appealing target to inhibit can...

    Authors: Jiaxin Fan, Yanru Fan, Xiao Wang, Lingfang Niu, Limei Duan, Jinxiao Yang, Luo Li, Yingying Gao, Xiaohou Wu and Chunli Luo

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:337

    Published on:

  39. Content type: Research

    Pancreatic Ductal Adenocarcinoma (PDAC) is an aggressive and lethal disease, lacking effective therapeutic approaches. Available therapies only marginally prolong patient survival and are frequently coupled wi...

    Authors: Aleksandra Adamska, Alice Domenichini, Emily Capone, Verena Damiani, Begum Gokcen Akkaya, Kenneth J. Linton, Pierluigi Di Sebastiano, Xi Chen, Adam B. Keeton, Veronica Ramirez-Alcantara, Yulia Maxuitenko, Gary A. Piazza, Vincenzo De Laurenzi, Gianluca Sala and Marco Falasca

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:312

    Published on:

  40. Content type: Correction

    In the original publication of this article [1], the authors reported the order of the authors was incorrect and needs to be revised. The original article has been updated to rectify this error.

    Authors: Qing Yang, Binhui Xie, Hui Tang, Wei Meng, Changchang Jia, Xiaomei Zhang, Yi Zhang, Jianwen Zhang, Heping Li and Binsheng Fu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:336

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:263

  41. Content type: Research

    The chemical carcinogen 3-methylcholanthrene (3MC) binds to the aryl hydrocarbon receptor (AHR) that regulates the expression of cytochrome P450 (CYP) enzymes as CYP1B1, which is involved in the oncogenic acti...

    Authors: Francesca Cirillo, Rosamaria Lappano, Leonardo Bruno, Bruno Rizzuti, Fedora Grande, Rita Guzzi, Sara Briguori, Anna Maria Miglietta, Miki Nakajima, Maria Teresa Di Martino and Marcello Maggiolini

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:335

    Published on:

  42. Content type: Research

    Runt-related transcription factor 1 (RUNX1) plays the roles of an oncogene and an anti-oncogene in epithelial tumours, and abnormally elevated RUNX1 has been suggested to contribute to the carcinogenesis of co...

    Authors: Qingyuan Li, Qiuhua Lai, Chengcheng He, Yuxin Fang, Qun Yan, Yue Zhang, Xinke Wang, Chuncai Gu, Yiqing Wang, Liangying Ye, Lu Han, Xin Lin, Junsheng Chen, Jianqun Cai, Aimin Li and Side Liu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:334

    Published on:

  43. Content type: Research

    Cathepsin L (CTSL) is a cysteine protease known to have important roles in regulating cancer cellular resistance to chemotherapy. However mechanism underlying which regulates CTSL-mediated drug resistance rema...

    Authors: Yifan Zhao, Xiao Shen, Ying Zhu, Anqi Wang, Yajie Xiong, Long Wang, Yao Fei, Yan Wang, Wenjuan Wang, Fang Lin and Zhongqin Liang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:333

    Published on:

  44. Content type: Research

    Immunotherapeutic approaches designed to augment T and B cell mediated killing of tumor cells has met with clinical success in recent years suggesting tremendous potential for treatment in a broad spectrum of ...

    Authors: Lawrence H. Cheung, Yunli Zhao, Ana Alvarez-Cienfuegos, Khalid A. Mohamedali, Yu J. Cao, Walter N. Hittelman and Michael G. Rosenblum

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:332

    Published on:

  45. Content type: Correction

    In the original publication of this article [1], the Gene Expression Omnibus (GEO) accession code GSE79772 is wrong. The correct accession code should be GSE86213.

    Authors: Yinfang Wang, Yanli Hou, Weiwei Zhang, Angel A. Alvarez, Yongrui Bai, Bo Hu, Shi-Yuan Cheng, Kun Yang, Yanxin Li and Haizhong Feng

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:331

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:147

  46. Content type: Research

    RelA/p65 a crucial member of NF-κB signaling pathway plays diverse role in mediating oncogenesis. Limited knowledge prevails on the mechanistic insights of RelA gene regulation. RNA helicase p68 apart from bei...

    Authors: Veenita Khare, Shaheda Tabassum, Uttara Chatterjee, Sandip Chatterjee and Mrinal K. Ghosh

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:330

    Published on:

  47. Content type: Research

    Kinesins play important roles in the development and progression of many human cancers. The functions and underlying mechanisms of kinesin family member C1 (KIFC1), a member of the kinesin-14 family, in the pa...

    Authors: Kai Teng, Shi Wei, Chi Zhang, Jiewei Chen, Jinbin Chen, Kanghua Xiao, Jun Liu, Miaomiao Dai, Xinyuan Guan, Jingping Yun and Dan Xie

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:329

    Published on:

  48. Content type: Review

    Tumor heterogeneity results in differential response to therapy due to the existence of plastic tumor cells, called cancer stem cells (CSCs), which exhibit the property of resistance to therapy, invasion and m...

    Authors: Pavana Thomas, Annapurna Pranatharthi, Cecil Ross and Sweta Srivastava

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:328

    Published on:

  49. Content type: Review

    Malignant tumors are often multifactorial. Epidemiological studies have shown that hyperglycemia raises the prevalence and mortality of certain malignancies, like breast, liver, bladder, pancreatic, colorectal...

    Authors: Wenjie Li, Xuehui Zhang, Hui Sang, Ying Zhou, Chunyu Shang, Yongqing Wang and Hong Zhu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:327

    Published on:

  50. Content type: Research

    Prostate cancer (PCa) is the second leading cause of cancer-related death in the Western population. The use in oncology of positron emission tomography/computed tomography (PET/CT) with emerging radiopharmace...

    Authors: B. Frigerio, S. Morlino, E. Luison, E. Seregni, A. Lorenzoni, A. Satta, R. Valdagni, A. Bogni, C. Chiesa, M. Mira, S. Canevari, A. Alessi and M. Figini

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:326

    Published on:

Follow

Annual Journal Metrics

Advertisement

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us